MalF is essential for persistence of Mycoplasma gallisepticum in vivo
- PMID: 23657682
- DOI: 10.1099/mic.0.067553-0
MalF is essential for persistence of Mycoplasma gallisepticum in vivo
Abstract
There is limited understanding of the molecular basis of virulence in the important avian pathogen Mycoplasma gallisepticum. To define genes that may be involved in colonization of chickens, a collection of mutants of the virulent Ap3AS strain of M. gallisepticum were generated by signature-tagged transposon mutagenesis. The collection included mutants with single insertions in the genes encoding the adhesin GapA and the cytadherence-related protein CrmA, and Western blotting confirmed that these mutants did not express these proteins. In two separate in vivo screenings, two GapA-deficient mutants (ST mutants 02-1 and 06-1) were occasionally recovered from birds, suggesting that GapA expression may not always be essential for persistence of strain Ap3AS. CrmA-deficient ST mutant 33-1 colonized birds poorly and had reduced virulence, indicating that CrmA was a significant virulence factor, but was not absolutely essential for colonization. ST mutant 04-1 contained a single transposon insertion in malF, a predicted ABC sugar transport permease, and could not be reisolated even when inoculated by itself into a group of birds, suggesting that expression of MalF was essential for persistence of M. galliseptium strain Ap3AS in infected birds.
Similar articles
-
Identification of a virulence-associated determinant, dihydrolipoamide dehydrogenase (lpd), in Mycoplasma gallisepticum through in vivo screening of transposon mutants.Infect Immun. 2006 Feb;74(2):931-9. doi: 10.1128/IAI.74.2.931-939.2006. Infect Immun. 2006. PMID: 16428737 Free PMC article.
-
Metabolite profiling of Mycoplasma gallisepticum mutants, combined with bioinformatic analysis, can reveal the likely functions of virulence-associated genes.Vet Microbiol. 2018 Sep;223:160-167. doi: 10.1016/j.vetmic.2018.08.001. Epub 2018 Aug 2. Vet Microbiol. 2018. PMID: 30173742
-
A Mycoplasma gallisepticum Glycerol ABC Transporter Involved in Pathogenicity.Appl Environ Microbiol. 2021 May 11;87(11):e03112-20. doi: 10.1128/AEM.03112-20. Print 2021 May 11. Appl Environ Microbiol. 2021. PMID: 33741628 Free PMC article.
-
Haemagglutinins of pathogenic avian mycoplasmas.Avian Pathol. 2002 Dec;31(6):535-47. doi: 10.1080/0307945021000024526. Avian Pathol. 2002. PMID: 12593736 Review.
-
PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics.Pharmacogenet Genomics. 2020 Jun;30(4):81-90. doi: 10.1097/FPC.0000000000000397. Pharmacogenet Genomics. 2020. PMID: 32187155 Free PMC article. Review. No abstract available.
Cited by
-
Variable Lipoprotein Hemagglutinin A Gene (vlhA) Expression in Variant Mycoplasma gallisepticum Strains In Vivo.Infect Immun. 2018 Oct 25;86(11):e00524-18. doi: 10.1128/IAI.00524-18. Print 2018 Nov. Infect Immun. 2018. PMID: 30181349 Free PMC article.
-
Genome Editing of Veterinary Relevant Mycoplasmas Using a CRISPR-Cas Base Editor System.Appl Environ Microbiol. 2022 Sep 13;88(17):e0099622. doi: 10.1128/aem.00996-22. Epub 2022 Aug 24. Appl Environ Microbiol. 2022. PMID: 36000854 Free PMC article.
-
Mycoplasma Biofilms: Characteristics and Control Strategies.Microorganisms. 2025 Aug 7;13(8):1850. doi: 10.3390/microorganisms13081850. Microorganisms. 2025. PMID: 40871354 Free PMC article. Review.
-
Genes required for survival and proliferation of Mycoplasma bovis in association with host cells.Appl Environ Microbiol. 2024 Jul 24;90(7):e0068724. doi: 10.1128/aem.00687-24. Epub 2024 Jun 12. Appl Environ Microbiol. 2024. PMID: 38864628 Free PMC article.
-
Development of Molecular Methods for Rapid Differentiation of Mycoplasma gallisepticum Vaccine Strains from Field Isolates.J Clin Microbiol. 2019 May 24;57(6):e01084-18. doi: 10.1128/JCM.01084-18. Print 2019 Jun. J Clin Microbiol. 2019. PMID: 30971467 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources